![Comparative in-vitro evaluation of antibacterial activity of levofloxacin brands available in Pakistan » Advancements in Life Sciences Comparative in-vitro evaluation of antibacterial activity of levofloxacin brands available in Pakistan » Advancements in Life Sciences](http://www.als-journal.com/articles/vol2issue4/244.15/Figure1.jpg)
Comparative in-vitro evaluation of antibacterial activity of levofloxacin brands available in Pakistan » Advancements in Life Sciences
![Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial - The Lancet Oncology Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/asset/046c525d-65cd-4490-8082-4091bd898c6f/gr1.jpg)
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial - The Lancet Oncology
![Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients - ScienceDirect Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095461110600165X-gr1.jpg)